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The ability of vertebrates to detect and avoid damag-
ing extremes of temperature depends on activation
of ion channels belonging to the thermo-TRP family.
Injury or inflammation causes the release of inflam-
matory mediators which lower the threshold for de-
tection of painful levels of heat, a process known as
heat hyperalgesia. These inflammatory mediators
act by at least three distinct intracellular signaling
pathways. Here, we show that modulation of the sen-
sitivity of the heat-activated ion channel TRPV1 by
the protein kinases PKA and PKC and by the phos-
phatase calcineurin depends on the formation of
a signaling complex between these enzymes, the
scaffolding protein AKAP79/150 and TRPV1. We
identify a critical region in the TRPV1 C-terminal
which mediates binding of AKAP79/150. If binding
is prevented, then sensitization by both bradykinin
and PGE2 is abrogated. AKAP79/150 is therefore a fi-
nal common element in heat hyperalgesia, on which
the effects of multiple proinflammatory mediators
converge.
INTRODUCTION
Animals detect thermal stimuli via the activation of primary sen-
sory nerve terminals responding to a range of temperatures from
noxious cold, through the innocuous range, and extending to
damaging extremes of heat (Darian-Smith, 1984; Perl, 1984;
Lumpkin and Caterina, 2007). Thermal stimuli activate inward
membrane currents in temperature-sensitive neurons (Cesare
and McNaughton, 1996; Reid and Flonta, 2001), and they do
so by the direct activation of temperature-sensitive ion channels
belonging to the thermo-TRP family (Jordt et al., 2003; Venkata-
chalam and Montell, 2007; Nilius et al., 2007). The best-studied
thermo-TRPs are as follows: TRPV1, which is activated by nox-
ious temperatures above 43C (Caterina et al., 1997); TRPV2,
activated by higher temperatures, above 52C (Caterina et al.,
1999); TRPV3 and TRPV4, activated in the range of innocuous
warmth, c. 35C–37C (Smith et al., 2002; Xu et al., 2002; Guler
et al., 2002; Watanabe et al., 2002); TRPM8, activated by cooling
below c. 30C (McKemy et al., 2002); and TRPA1, which may be450 Neuron 59, 450–461, August 14, 2008 ª2008 Elsevier Inc.activated by more extreme cooling (Story et al., 2003), though
other recent studies have failed to confirm the activation of
this ion channel by cold (Bautista et al., 2006; Zurborg et al.,
2007).
The temperature thresholds of thermally activated ion chan-
nels are modulated by a range of extracellular factors (Huang
et al., 2006). The temperature threshold of TRPV1, the best-stud-
ied thermo-TRP channel, is lowered by proinflammatory media-
tors such as bradykinin, prostaglandin E2 (PGE2), and nerve
growth factor (NGF). The lowering of the TRPV1 threshold is crit-
ical for heat hyperalgesia, the process by which the threshold for
heat pain is lowered following inflammation or injury, because
heat hyperalgesia is ablated when TRPV1 is genetically deleted
(Davis et al., 2000; Caterina et al., 2000).
Three pathways are known to lead to sensitization of TRPV1.
The activation of the Gq-coupled B1 and B2 receptors by brady-
kinin lowers the temperature threshold of TRPV1 by promoting
phosphorylation by PKC3 (Cesare and McNaughton, 1996; Ce-
sare et al., 1999; Numazaki et al., 2002; Bhave et al., 2003). An
alternative possibility, that metabolism of PIP2 by PLCb may re-
lease TRPV1 from PIP2-mediated inhibition (Chuang et al., 2001),
is not supported by more recent evidence showing that PIP2 in
fact activates rather than inhibiting TRPV1 (Stein et al., 2006;
Lishko et al., 2007). In sensory neurons, PGE2 activates the
EP4 receptor, which is Gs coupled and causes sensitization by
promoting PKA-dependent phosphorylation of TRPV1 (Bhave
et al., 2002; Distler et al., 2003). In a third pathway leading to sen-
sitization of TRPV1, NGF potentiates TRPV1 by activating PI3 ki-
nase and the tyrosine kinase Src, leading to phosphorylation of
TRPV1 at Y200 and to promotion of trafficking of TRPV1 to the
neuronal cell membrane (Zhang et al., 2005; Stein et al., 2006).
A proposal that NGF sensitizes TRPV1 by activating PLCg and
thus reducing levels of PIP2 (Chuang et al., 2001; Prescott and
Julius, 2003) is not supported by more recent evidence (Zhang
et al., 2005).
The speed and specificity of the action of kinases is in many
cases enhanced by the use of scaffolding proteins which preas-
semble the kinases into signaling complexes with their sub-
strates. The AKAP (A kinase anchoring protein) family of scaf-
folding proteins were originally named for their ability to target
PKA to appropriate substrates but are now known to assemble
a wide range of kinases and phosphatases into signaling com-
plexes with appropriate targets (Leiser et al., 1986; Bregman
et al., 1989; reviewed by Smith et al., 2006). AKAP79/150 targets
PKA, PKC, and the Ca-dependent phosphatase calcineurin to
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AKAP79 Controls Sensitivity of TRPV1appropriate substrates (Coghlan et al., 1995; Klauck et al., 1996).
AKAP79 is the human homolog, while AKAP150, the rodent ho-
molog, seems to be similar in function to AKAP79 but contains
an additional large central domain.
A number of ion channels are subject to modulation by
AKAPs, including glutamate receptors, calcium channels, and
M-type potassium channels (Gao et al., 1997; Colledge et al.,
2000; Altier et al., 2002; Hoshi et al., 2003, 2005; Sandoz
et al., 2006; Oliveria et al., 2007; Lu et al., 2007; Chai et al.,
2007; Navedo et al., 2008). An AKAP may be involved in the
Figure 1. AKAP150 Is Coexpressed with
TRPV1 in Sensory Neurons
(A) TRPV1 (left) and AKAP150 (center) coexpress
in small (<25 mm dia) rat DRG neurons (merged im-
age at right). The majority of TRPV1 is present in
subcellular vesicles (Zhang et al., 2005). 91.1% ±
1.7% of TRPV1-positive neurons express
AKAP150 (n = 352; values given as mean ± SEM
in this and all subsequent instances). Scale bar
10 mm.
(B) Immunoprecipitating TRPV1 from rat DRG
neurons coimmunoprecipitates AKAP150 (upper
blot, right lane). A control experiment using rat
IgG does not immunoprecipitate either TRPV1 or
AKAP150.
(C) AKAP150 can be downregulated in rat DRG
neurons by the use of an siRNA against
AKAP150. The vector chosen for the siRNA ex-
pression also coexpressed GFP so that success-
fully transfected neurons could be identified (left
column). A scrambled siRNA had no effect on
AKAP150 levels in successfully transfected neu-
rons (top), but the siRNA against AKAP150 down-
regulated expression (middle; mean 12.1% ±
1.9% of untransfected neurons in same images,
n = 6). Lower pair of images compares the effect
of siRNA in adjacent transfected and untrans-
fected neurons. Scale bar 20 mm.
(D) Similar experiment in which AKAP79 in
HEK293 cells was downregulated to a mean value
of 15.9% ± 2.6% of control (n = 22) by the use of an
siRNA against AKAP79. AKAP79 and siRNA
against AKAP79 were simultaneously coex-
pressed. Scale bar 10 mm.
(E) Western blot showing downregulation of
AKAP79 in HEK293 cells by siRNA and lack of ef-
fect of scrambled siRNA. Mean downregulation
was to 30.4% ± 2.5% of control (n = 3), but note
that this includes some untransfected cells
(c. 20% of total). Bottom image shows same blot
stripped and reprobed for b tubulin to check simi-
lar loading in each lane.
modulation of TRPV1 by PKA (Rathee
et al., 2002; Distler et al., 2003), but nei-
ther the AKAP family member involved
nor its binding site on TRPV1 have been
identified, and the possibility that other
kinases such as PKC and Src may also
be assembled into a functional signaling
complex important in the regulation of
TRPV1 has not been explored. These questions are addressed
in the present paper.
RESULTS
Coexpression of AKAP79/150 and TRPV1 in Sensory
Neurons
Several AKAPs are expressed in sensory neurons, among them
AKAP79/150 (Rathee et al., 2002). Figure 1A shows that the vast
majority of rat DRG neurons which express TRPV1 (left panel)Neuron 59, 450–461, August 14, 2008 ª2008 Elsevier Inc. 451
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panel). We found that 91.1% ± 1.7% of neurons expressing
TRPV1 also expressed AKAP150 (mean ± SEM; n = 352). Evi-
dence for a physical association between the two in sensory
neurons was obtained in coimmunoprecipitation experiments
in which pull-down of TRPV1, using an antibody raised to the
TRPV1 N-terminal domain, also brought down AKAP150
(Figure 1B).
In later experiments in this study it was important to be able to
manipulate endogenous AKAP79/150 levels in both DRG neu-
rons and in a HEK293 expression system. We constructed an
siRNA against AKAP150 and AKAP79, as used by Hoshi et al.
(2005) but in a vector which coexpresses GFP to enable identifi-
cation of successfully transfected cells. The siRNA against
AKAP150 reduced expression levels in transfected rat DRG neu-
rons to 12.1% ± 1.9% of control (Figure 1C; n = 6), and the siRNA
against AKAP79 reduced expression in HEK293 cells to 15.9% ±
2.6% of control (Figure 1D; n = 22). A similar but lesser downre-
gulation was seen in Western blots of HEK293 cell protein
(Figure 1E; 30.4% ± 2.5% of control, n = 3), a difference which
is expected because not all cells are transfected. In all cases
a scrambled siRNA with the same base composition was com-
pletely ineffective (Figures 1C–1E).
Binding of AKAP79 to Thermo-TRPs
The experiments in Figure 2 show that AKAP79 expressed in
HEK293 cells binds to several members of the thermo-TRP fam-
ily of ion channels. AKAP79 expressed in HEK293 cells coimmu-
noprecipitates with several thermo-TRPs (Figures 2A and 2B),
particularly with TRPV1 and TRPV4, and to a lesser extent
TRPM8 and TRPA1. Endogenous AKAP79 can also coimmuno-
precipitate lesser amounts of TRPV1 (Figure 2B, top left panel).
Figure 2C shows that the binding between TRPV1 and AKAP79
does not depend on the use of the V5 tag attached to the C-ter-
minal as it is also observed when an antibody raised to the N-ter-
minal TRPV1 domain is used.
We next localized the TRPV1 binding site for AKAP79 by con-
structing GST-coupled fragments of the four intracellular do-
mains of TRPV1, expressed in bacteria, and exploring binding
to AKAP79 in vitro. The major binding domain is in the C-termi-
nal portion of TRPV1 (Figure 2D), with only weak binding
observed to the large N-terminal domain and no detectable
binding to either of the intracellular loops. When the GST-cou-
pled C-terminal domain was progressively truncated, there
was an increase in binding on removal of the region between
amino acids 759 and 777, probably because of removal of an
inhibitory region, but more significantly there was a substantial
loss of binding on removal of amino acids 736 to 749
(Figure 2E, left panel; note that all residue numbering is for
hTRPV1). Deletion of just this region caused a major reduction
in binding, while other nearby deletions were much less effec-
tive (Figure 2E, right panel). We repeated this deletion in intact
TRPV1, expressed in HEK293 cells, and found that removal of
this region also caused a substantial reduction in the binding
of AKAP79 to intact TRPV1 (see Figure S1A available online).
We next constructed a 14 aa peptide, identical to this binding
domain, which should be able to compete for the site on
AKAP79 to which TRPV1 binds. At a concentration of 200 mM452 Neuron 59, 450–461, August 14, 2008 ª2008 Elsevier Inc.this peptide largely prevented binding of AKAP79 to the GST-
coupled C-terminal fragment of TRPV1, while a scrambled pep-
tide of the same composition was ineffective (Figure 2F). The
peptide was also highly effective in displacing AKAP79 from
binding to intact TRPV1 (Figure 2G).
AKAP79/150 Promotes Activation of TRPV1
We found that expression of AKAP79 enhanced the sensitivity of
TRPV1 to capsaicin even in the absence of overt activation of
PKC or PKA by proinflammatory mediators (Figure 3A, compare
red points and red curve with black points and black curve). Con-
versely, expression of AKAP79 with the PKC binding site deleted
(Hoshi et al., 2005) reduced the sensitivity of TRPV1 to activation
by capsaicin (green points and curve). The fact that AKAP79 can
enhance sensitivity, while deletion of the PKC binding site on
AKAP79 has a dominant-negative effect, shows that phosphor-
ylation by PKC is important in modulating sensitivity of TRPV1
even in the resting cell. The results also show that endogenous
AKAP79 does not saturate its binding sites on TRPV1, because
overexpression of AKAP79 has an effect greater than that of
endogenous AKAP79.
Deletion of the PKA binding site had a smaller effect than de-
letion of the PKC site (gray squares), showing that phosphoryla-
tion by constitutively active PKA is less important than PKC in the
resting cell. The effect of expression of an AKAP79 with the cal-
cineurin (PP2B) binding site deleted was indistinguishable from
that of wild-type AKAP79 (blue points), suggesting that calci-
neurin bound to AKAP79 makes little contribution to dephos-
phorylating TRPV1 at resting levels of calcium.
TRPV1 ion channels can be opened even in the absence of
agonist by strong membrane depolarization (Voets et al.,
2004). Activation of PKC potentiates this process by enabling
opening of TRPV1 at lower membrane potentials (Matta and
Ahern, 2007), and our demonstration that AKAP79 is involved
in potentiation of TRPV1 by PKC suggests that it will have a sim-
ilar effect. Figure 3B shows that activating PKC or overexpress-
ing AKAP79 both have similar effects in potentiating the opening
of TRPV1 by membrane depolarization, and moreover that the
actions are to some extent additive. Figures 3C and 3D demon-
strate that overexpression of AKAP79 shifts the voltage activa-
tion curve to less depolarized potentials by 54 mV, and that sub-
sequent full activation of PKC causes an additional 32 mV
negative shift. In summary, the experiments in Figure 3 show
that expression of AKAP79 promotes activation of TRPV1 by
both capsaicin and membrane potential, and moreover that
this action depends mainly on the binding of PKC to AKAP79.
AKAP79/150 Is Essential for Sensitization of TRPV1 via
PKC and PKA Pathways
We next investigated whether AKAP79/150 mediates the sensi-
tization of TRPV1 caused by proinflammatory mediators. For
these experiments, we used a low dose of capsaicin as a conve-
nient activator of TRPV1, because the sensitivity of TRPV1 to
heat, capsaicin, low pH, and a range of other activators is known
to be enhanced in a similar way by proinflammatory mediators
(Vellani et al., 2001).
In rat sensory neurons, bradykinin caused a substantial
enhancement of the inward current mediated by TRPV1
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AKAP79 Controls Sensitivity of TRPV1(Figure 4A), a process which has been shown to be due to phos-
phorylation of serines 502 and 801 by PKC3 (Cesare and
McNaughton, 1996; Cesare et al., 1999; Numazaki et al., 2002;
Bhave et al., 2003). Incorporation of the 14 aa peptide which
prevents binding of AKAP150 to TRPV1 completely inhibited
sensitization by Bk, while the scrambled peptide was ineffective
(Figures 4A and 4B). An alternative way of demonstrating an in-
volvement of AKAP150 is to downregulate endogenous expres-
sion using siRNA. Figures 4A and 4B show that removal of
AKAP150 in this way almost completely inhibited the action of
Bk in sensory neurons, while a scrambled siRNA was ineffective.
Finally, simultaneously transfecting with AKAP79, which is insen-
sitive to the siRNA against AKAP150 (Hoshi et al., 2005), rescued
the sensitization by BK, and in fact the overexpression of
AKAP79 causes an enhanced level of sensitization (final bar,
Figure 4B).
Figure 2. AKAP79 Binds to a Region in the
TRPV1 C-Terminal Domain
(A) Members of the thermo-TRP family of ion chan-
nels coimmunoprecipitate AKAP79. TRP proteins
were immunoprecipitated with an antibody to
a V5 tag fused to the TRP C termini, and associa-
tion of cotransfected AKAP79 was probed as
shown in top blot. Expression levels of TRP pro-
teins were similar in all cases (middle blot, which
is top blot stripped and reprobed), apart from the
first lane in which no TRP was transfected. Note
the double principal bands for most TRPs, due to
the presence of glycosylated (mature) and nongly-
cosylated (immature) protein (Jahnel et al., 2001).
The V5 antibody does not crossreact with any en-
dogenous HEK293 cell proteins (see left lane, in
which no TRP was transfected), and fainter bands
of lower M.Wt. are due to the presence of trun-
cated versions of the V5-tagged TRPs. Lower
blot of total cell lysate (TCL) shows that AKAP79
expression was similar in all lanes.
(B) Converse experiment to that shown in (A);
AKAP79 was immunoprecipitated and associa-
tion with the TRP proteins shown at top was
probed with the V5 antibody. Association of TRP
proteins with AKAP79 in both (A) and (B) was in
the order TRPV1zTRPV4 > TRPA1zTRPM8 >
TRPV2zTRV3. Note that endogenous AKAP79
expressed in HEK293 cells (left lane, middle panel)
precipitates TRPV1, though to a lesser extent,
even in the absence of transfected AKAP79 (see
top panel, weak band in left lane).
(C) CoIP of TRPV1 and AKAP79 demonstrated
without use of the V5 antibody. Immunoprecipita-
tion with a TRPV1 antibody raised to the N-termi-
nal (right lane) coIPs AKAP79.
(D) GST-coupled fragments of the hTRPV1 N-ter-
minal (residues 1–433), intracellular loop 1 (498–
513), intracellular loop 2 (557–579), and C-terminal
(681–839) were expressed in E. coli, purified, and
tested for their ability to coIP AKAP79. Note that
all residue numbering is for the hTRPV1 used in
these experiments. Bottom image, from an inde-
pendent run, shows Coomassie stain of similar
gel to demonstrate that expression levels of
GST-coupled constructs were similar in all lanes.
Principal band in each lane is the GST-coupled
construct; other bands are bacterial proteins in-
completely removed during purification.
(E) GST-coupled fragments of the hTRPV1 C-terminal domain (681–839) were truncated as shown (left) or internal regions were deleted (right) and were exam-
ined for ability to coimmunoprecipitate AKAP79. Bottom image at left shows GST-coupled fragments stained with Coomassie in an independent run; bottom
image at right shows blot above stripped and reprobed for GST to demonstrate similar loading in all lanes.
(F) A 14 aa peptide of sequence KDDYRWCFRVDEVN, corresponding to residues 736–749 of hTRPV1, displaces binding between AKAP79 and TRPV1 GST-
coupled C-terminal. A peptide with the same composition but with scrambled sequence VCEYDVFDRNDKWR is ineffective.
(G) Inhibitory peptide (see [F]) displaces binding between intact TRPV1 and AKAP79, while scrambled peptide is ineffective. Peptide added at stated final con-
centrations directly to lysate of HEK293 cells transfected with TRPV1 and AKAP79.Neuron 59, 450–461, August 14, 2008 ª2008 Elsevier Inc. 453
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AKAP79 Controls Sensitivity of TRPV1Bradykinin also caused a substantial sensitization of TRPV1 in
HEK293 cells transfected with the Gq-coupled B2 receptor
(Figure 4C). Sensitization was abolished by deletion of the PKC
binding site on AKAP79, by downregulation of endogenous
AKAP79 with siRNA, or by mutation of the S502 and S801 sites
on TRPV1, which are known targets for phosphorylation by PKC
(Numazaki et al., 2002; Bhave et al., 2003; see Figure 4D). Deletion
of the PKA binding site, however, had a lesser effect than deletion
of the PKC site (Figure 2C), as expected because PKC is the main
kinase activated by bradykinin. The experiments in Figure 4 show
that simple activation of PKC by a proinflammatory mediator such
as bradykinin is insufficient to cause sensitization of TRPV1. For-
mation of a scaffolding complex between TRPV1, AKAP79, and
PKC is an essential prerequisite for PKC to sensitize TRPV1.
A second important proinflammatory mediator is the prosta-
glandin PGE2, which sensitizes TRPV1 in sensory neurons via
both the Gq-coupled EP1 receptor and the Gs-coupled EP4 re-
ceptor (Lopshire and Nicol, 1998; Southall and Vasko, 2001;
Bhave et al., 2002; Moriyama et al., 2005; Lin et al., 2006). We
found that application of PGE2 to isolated rat sensory neurons
caused a substantial sensitization, and as was the case with
Bk, sensitization by PGE2 was completely ablated by inclusion
of the 14 aa peptide which blocks the AKAP79/150-TRPV1 inter-
action (Figures 5A and 5B). Downregulating endogenous
AKAP150 by the use of siRNA had a similar inhibitory effect,
and transfection of AKAP79 rescued the sensitization by PGE2.
Interestingly, overexpression of AKAP79 did not produce a level
of sensitization above that in untransfected neurons, in contrast
to the enhanced sensitization seen with Bk. This difference is dis-
cussed further below.
In HEK293 cells coexpressing TRPV1 and the Gq-coupled EP1
receptor, application of PGE2 caused significant sensitization
Figure 3. AKAP79 Promotes Activation of
TRPV1
(A) Peak inward current as a function of capsaicin
concentration (5 s pulse) in HEK293 cells trans-
fected with hTRPV1. Control dose-response rela-
tion (black points and curve, K½ = 244 nM, Hill co-
efficient 1.82) is sensitized, i.e., displaced to lower
capsaicin concentrations with no change in Hill
coefficient, by cotransfection with AKAP79 (red
points and curve, K½ = 92 nM), and desensitized
by cotransfection with AKAP79 with the PKC bind-
ing site deleted (green points and curve, K½ = 634
nM). Deletion of PKA binding site of AKAP79
(squares, K½ = 180 nM, curve not shown) reduced
sensitivity less than deletion of the PKC binding
site, while deletion of the calcineurin binding site
was indistinguishable from WT AKAP79 (blue
points, K½ = 112 nM, curve not shown).
(B) Whole-cell voltage-clamp experiments on
HEK293 cells. Voltage-clamp pulse protocol
shown at left. Other traces show currents in cells
transfected with hTRPV1 and with transfected
AKAP79 and/or exposed to PMA (1 mM) as indi-
cated. In this and all other current traces, the
zero level is indicated by a horizontal line to the
left of the first current trace.
(C) Activation of TRPV1 by membrane voltage.
Points derived from traces shown in (B), as de-
tailed in Experimental Procedures. Curves are
Boltzmann functions best-fitted to experimental
points (see Supplemental Experimental Proce-
dures). Values of the half-activation voltage, V½,
and the steepness factor, k, were as follows:
TRPV1 alone, 194 mV, 51 mV; TRPV1 + PMA,
140 mV, 32 mV; TRPV1 + AKAP79, 131 mV, 41
mV; TRPV1 + AKAP79 + PMA, 108 mV, 35 mV.
The steepness factor k was not significantly differ-
ent among the different conditions and corre-
sponded to a gating charge of z = 0.64 (see Nilius
et al., 2005).
(D) Average values of V½ obtained in experiments
such as those shown in (B) and (C). Numbers of ex-
periments for each bar are (from left) 14, 13, 43,
and 20. Error bars show ± SEM in this and all sub-
sequent figures. Significance levels are **, p < 0.01
and ***, p < 0.001 with respect to TRPV1 alone;
###, p < 0.001 with respect to TRPV1 + AKAP79.454 Neuron 59, 450–461, August 14, 2008 ª2008 Elsevier Inc.
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AKAP79 Controls Sensitivity of TRPV1Figure 4. AKAP79 Mediates Sensitization of TRPV1 by Bradykinin
(A) Whole-cell voltage clamp experiments on small (<25 mm dia) rat DRG neu-
rons. From top: bradykinin causes potent sensitization of inward current acti-
vated by a subsaturating pulse of capsaicin (100 nM, 5 s); inclusion of blocking
peptide (200 mM) in the patch clamp pipette abolished sensitization; downre-
gulation of AKAP150 by the use of siRNA largely abolished sensitization; sen-
sitization was rescued by cotransfection of AKAP79, which is insensitive to the
siRNA against AKAP150. These experiments were conducted in the presence
of 1.8 mM external [Ca2+], so substantial desensitization is observed in re-
sponse to successive applications of capsaicin following application of Bk.
Note that almost all TRPV1-positive neurons also expressed B2 receptors
for Bk, as shown from the observation that >90% of naive neurons responding
to capsaicin showed an enhancement of response following exposure to Bk.
The suppression of sensitization by the inhibitory peptide or siRNA cannot
therefore be attributed to chance selection of neurons not expressing recep-
tors for Bk.
(B) Collected results of experiments similar to those in (A). Bars show maxi-
mum amplitude of first response following application of Bk relative to last re-
sponse before application. Bradykinin caused sensitization (bar 2; *, p < 0.05
compared to control, n = 19). Inclusion of peptide abolished sensitization (bar
3; ###, p < 0.001 compared to bar 2, n = 23). Scrambled peptide was ineffec-
tive in reversing sensitization by bradykinin (bar 4; *, p < 0.05 compared to con-
trol, n = 13). siRNA against AKAP150 largely abolished sensitization (bar 5; #,
p < 0.05 compared to bar 2, n = 15), but this effect was not seen with scram-
bled siRNA (bar 6; *, p < 0.05 compared to control, n = 20). Abolition of sensi-
tization following transfection with siRNA could be rescued by cotransfection
of AKAP79, which is insensitive to the siRNA against AKAP150 (bar 7; ##, p <
0.01 compared to bar 2, n = 22).
(C) Whole-cell voltage-clamp experiments on HEK293 cells transfected with
TRPV1 and bradykinin B2 receptor. Bradykinin (1 mM) caused potent sensitiza-
tion of the inward current activated by a subsaturating pulse of capsaicin(Figure 5C, and see example traces in Figure S2A). Overexpres-
sion of AKAP79 enhanced sensitization (Figure 5C, bar 3), which
we attribute to a greater availability of the PKC binding site, an
explanation which is reinforced by the similar enhancement ob-
served when AKAP79 with the PKA site deleted was expressed
(Figure 5C, bar 4). Sensitization was abolished, however, by ex-
pression of AKAP79 with the PKC site deleted, or by downregu-
lation of endogenous AKAP79 by the use of siRNA (Figure 5C,
bars 5 and 6). These results show that sensitization of TRPV1
via the EP1 receptor is completely dependent on the presence
of AKAP79 containing a PKC binding site.
The results above show that PKC is able to phosphorylate
TRPV1 only when AKAP79/150 is available to position the kinase
appropriately. We also demonstrated this directly by the use of
a phosphoserine antibody (Figure S1B). Serine phosphorylation
was enhanced when PKC was activated with PMA, but when en-
dogenous AKAP79 was eliminated by transfection of siRNA, the
effect of PKC activation was abolished.
In HEK293 cells transfected with the Gs-coupled EP4 receptor,
we found that sensitization was abolished by deletion of the PKA
binding site on AKAP79 or by downregulation of endogenous
AKAP79 by the use of siRNA, while deletion of the PKC site
was without significant effect (Figure 5D, and see example traces
in Figure S2B). These results show that sensitization via the EP4
receptor depends on the presence of AKAP79 containing a func-
tional PKA binding site.
An interesting difference between Figures 5C and 5D, which is
also mirrored in the experiments on DRG neurons in Figures 4B
and 5B, is that sensitization via the PKC pathway is enhanced
when AKAP79/150 is overexpressed, but sensitization via the
PKA pathway is already maximal with endogenous levels of
AKAP79/150. Thus, endogenous levels of AKAP79/150 are not
adequate to ensure full phosphorylation of TRPV1 when PKC is
activated, and phosphorylation is boosted by transfection of fur-
ther AKAP79/150, while endogenous levels of AKAP79/150 are
adequate to ensure maximal phosphorylation of TRPV1 follow-
ing activation of PKA.
NGF sensitizes TRPV1 mainly by causing increased trafficking
to the surface membrane via a pathway involving the tyrosine ki-
nase Src (Zhang et al., 2005). Does this pathway also depend on
AKAP79/150? Figure 6A shows that NGF enhanced the mem-
brane current activated by a near-saturating concentration of
(20 nM, 5 s). Sensitization was abolished by cotransfection of AKAP79 with
the PKC binding site deleted, which has a dominant-negative effect, or by
downregulation of endogenous AKAP79 expression with siRNA. Note that
these experiments were conducted in the absence of external Ca2+, which ex-
plains why desensitization is absent.
(D) Collected results of experiments similar to those in (C). Bradykinin caused
potent sensitization (bar 2; ***, p < 0.001 compared to control, n = 25). Mutation
of either or both target phosphorylation sites S502 and S801 to alanine largely
abolished sensitization (bars 3–5, #, p < 0.05 and ##, p < 0.01 with respect to
bar 2; n = 5, 8, and 12). Overexpressing AKAP79 causes enhanced sensitiza-
tion (bar 6; #, p < 0.05 compared to bar 2, n = 16). Deleting the PKC binding site
on AKAP79 largely abolishes sensitization (bar 7; ##, p < 0.01 compared to bar
2, n = 23). Deleting the PKA binding site is less effective (bar 8; not significant
compared to bar 2, n = 10). Sensitization is abolished by downregulating ex-
pression of AKAP79 by the use of siRNA (bar 9; ###, p < 0.001 compared to
bar 2, n = 17).Neuron 59, 450–461, August 14, 2008 ª2008 Elsevier Inc. 455
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AKAP79 Controls Sensitivity of TRPV1Figure 5. Sensitization by PGE2 Is Mediated by AKAP79/150
(A) PGE2 causes potent sensitization of inward current activated by a subsatu-
rating pulse of capsaicin (100 nM, 5 s) in small DRG neurons. From top: control
neurons; blocking peptide (200 mM) included in the patch-clamp pipette abol-
ished sensitization; downregulation of AKAP150 with siRNA largely abolished
sensitization; sensitization was rescued by cotransfection of AKAP79. Break in
trace is 10 min period during which PGE2 was constantly perfused without ap-
plication of capsaicin.
(B) Collected results of experiments similar to those in (A). PGE2 caused sen-
sitization (bar 2; *, p < 0.05 compared to control, n = 9). Inclusion of peptide
abolished sensitization (bar 3; ##, p < 0.01 compared to bar 2, n = 13). SiRNA
against AKAP150 largely abolished sensitization (bar 4; ##, p < 0.01 compared
to bar 2, n = 19). Abolition of sensitization following transfection with siRNA
could be rescued by cotransfection of AKAP79 (bar 5; **, p < 0.01 compared
to control, n = 11).
(C) Collected results of whole-cell voltage-clamp experiments on HEK293 cells
transfected with TRPV1 and Gq-coupled prostaglandin EP1 receptor (see ex-
ample traces in Figure S2A). PGE2 (1 mM) caused potent sensitization (bar 2; **,
p < 0.01 compared to control, n = 27). Overexpressing AKAP79 causes en-
hanced sensitization (bar 3; ##, p < 0.01 compared to bar 2, n = 5). Deleting
the PKA binding site on AKAP79 has similar effect to WT AKAP79 (bar 4; ##,
p < 0.01 compared to bar 2, n = 15). Deleting the PKC binding site abolishes
sensitization (bar 5; #, p < 0.05 compared to bar 2, n = 20). Sensitization is abol-
ished by downregulating expression of AKAP79 by the use of siRNA (bar 6; #,
p < 0.05 compared to bar 2, n = 13).
(D) Similar experiments in HEK293 cells transfected with the Gs-coupled EP4
receptor (see example traces in Figure S2B). PGE2 (1 mM) caused potent sen-
sitization (bar 2; **, p < 0.01 compared to control, n = 13). Overexpressing
AKAP79 does not further enhance sensitization (bar 3; ***, p < 0.001 compared
to control, n = 6). Deleting the PKA binding site on AKAP79 abolishes sensiti-456 Neuron 59, 450–461, August 14, 2008 ª2008 Elsevier Inc.capsaicin, in agreement with previous studies (Zhang et al.,
2005; Stein et al., 2006). This effect is not, however, reduced
by inclusion of the AKAP-TRPV1-blocking peptide in the pipette.
We conclude that Src potentiates membrane trafficking of
TRPV1 via an AKAP79/150-independent mechanism.
Involvement of AKAP79/150 in Desensitization
AKAP79/150 contains a binding site for the calcium-dependent
phosphatase calcineurin (PP2B) (Coghlan et al., 1995; Klauck
et al., 1996), suggesting that AKAP79/150 could play a role in de-
sensitization of TRPV1, which is partly mediated by calcineurin
(Docherty et al., 1996; Koplas et al., 1997; Vellani et al., 2001).
In Figure 6C, we investigated desensitization by applying
a near-saturating conditioning dose of capsaicin, which evoked
a large inward current and caused strong desensitization of the
current evoked by a second capsaicin exposure. Note that in
these experiments, the magnitude of desensitization depends
strongly on the preceding calcium influx (Koplas et al., 1997),
and therefore it is important to select cells in which the calcium
influxes in response to the conditioning pulse are similar, partic-
ularly in view of the fact (see Figure 7C and discussion below)
that treatments such as upregulating AKAP79 by transfection
or downregulating it by the use of siRNA modulate the maximum
current amplitude. See legend to Figure 6D for further details.
Desensitization was largely abolished by removal of external
Ca (Figure 6D, bar 2). Overexpression of AKAP79 strongly en-
hanced desensitization, while downregulation of endogenous
AKAP79 by the use of siRNA substantially reduced it (Figures
6C and 6D, bars 3 and 4). AKAP79 with either the PKA site or
the PKC site deleted behaved similarly to WT AKAP79
(Figure 6D, bars 5 and 6), showing that these kinases are not in-
volved in desensitization when not activated by exogenous stim-
uli. Deletion of the calcineurin binding site, on the other hand, sub-
stantially reduced desensitization compared to that observed
with expression of WT AKAP79 (Figure 6D, last bar). In similar ex-
periments on sensory neurons, inclusion of the 14 aa blocking
peptide also reduced desensitization (Figures 6E and 6F).
These results implicate the calcineurin binding site of AKAP79
in the process of calcium-dependent desensitization of TRPV1.
We note, however, that while removal of extracellular calcium al-
most completely abolished desensitization, removing the in-
volvement of AKAP79, by downregulating AKAP79 with siRNA,
by deleting the calcineurin binding site, or (in neurons) by pre-
venting binding of AKAP79 to TRPV1 with the inhibitory peptide,
reduced but did not abolish desensitization (see Figures 6C–6F).
A likely explanation is that another Ca-dependent mechanism of
desensitization is also present, in addition to the calcineurin/
AKAP79 pathway. One possibility is that calmodulin may medi-
ate calcium-dependent desensitization of TRPV1, either by acti-
vating CaM kinase (Jung et al., 2004; Novakova-Tousova et al.,
2007) or by direct binding to a site in the intracellular N-terminal
domain (Lishko et al., 2007).
zation (bar 4; #, p < 0.05 compared to bar 2, n = 8). Deleting the PKC binding
site has no effect on sensitization (bar 5; *, p < 0.05 compared to control, n =
10). Sensitization is abolished by downregulating expression of AKAP79 by the
use of siRNA (bar 6; ##, p < 0.01 compared to bar 2, n = 7).
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AKAP79 Controls Sensitivity of TRPV1Figure 6. AKAP79 Partly Mediates Ca-Dependent Desensitization of
TRPV1
(A) AKAP79 does not mediate the sensitizing effects of NGF. From top: DRG
neurons were exposed to near-saturating pulses of capsaicin (5 s, 1 mM) sep-
arated by a 10 min interval; application of NGF between pulses (100 ng/ml, 10
min) enhanced the inward current activated by capsaicin; the enhancement
was not affected by inclusion of blocking peptide (200 mM) in the patch pipette.
(B) Collected results of experiments similar to those in (A). *, p < 0.05; **, p <
0.01 compared to control (n = 12, 15, 13).
(C) Activation of TRPV1 by a near-saturating dose of capsaicin (1 mM, 5 s)
causes strong desensitization to a subsequent capsaicin application (top
trace). Desensitization is enhanced by transfection of AKAP79 (middle trace)
and is reduced but not abolished by downregulation of AKAP79 with siRNA
(lower trace). Cells selected to have similar currents in response to condition-
ing application of capsaicin (see [D]).
(D) Collected results of experiments similar to those in (C). The magnitude of
desensitization depends on the amplitude of the preceding inward current
through TRPV1 (Koplas et al., 1997), so to control for this potential source of
variability data were only included from HEK293 cells with initial inward cur-
rents between 3.5 and 5.5 nA (i.e., current density between 100 and 200 pA/
pF). Desensitization is almost entirely Ca dependent (bar 2; ***, p < 0.001 com-
pared to bar 1, n = 12). Desensitization is enhanced by transfection of AKAP79
(bar 3; *, p < 0.05 compared to bar 1, n = 9) and is reduced but not abolished by
downregulating AKAP79 with siRNA (bar 4; *, p < 0.05 compared to bar 1, n =
8). Desensitization with PKA or PKC binding sites deleted is similar to WT
AKAP (bars 5, 6; *, p < 0.05, **, p < 0.01 compared to bar 1, n = 7,5), butAKAP79/150 Mediates Translocation of TRPV1 to the
Membrane
In Figure 7 we investigated a possible effect of AKAP79/150 on
trafficking of TRPV1 to the membrane. We first measured mem-
brane expression of TRPV1 using biotinylation of surface mem-
brane proteins (Figures 7A and 7B) or by expressing a functional
TRPV1 in which an HA tag had been engineered into the third ex-
tracellular loop (Figure 7H). We also obtained an independent
measure of surface membrane TRPV1 from the maximal mem-
brane current elicited by a saturating dose of capsaicin (Figures
7C and 7D). With all three methods, overexpression of AKAP79
caused a robust increase in surface membrane TRPV1 expres-
sion. Conversely, downregulation of AKAP79 using siRNA re-
duced but did not eliminate membrane expression (Figures 7C
and 7D). Deletion of either the PKC or the PKA binding site on
AKAP79 largely negates the effect of AKAP79 in promoting
translocation of TRPV1 to the membrane, while deletion of the
PP2B binding site is without effect (Figures 7A–7D). The PKA in-
hibitor H89 negates the effect of AKAP79 on trafficking of TRPV1
to the membrane (Figure 7G, last lane). Thus, AKAP79-mediated
phosphorylation of TRPV1 by both PKC and PKA is important in
translocation of TRPV1 to the membrane.
We next sought to identify the residues on TRPV1 whose
phosphorylation by PKC or PKA promotes trafficking to the
membrane. Mutating S502 abolished the enhanced membrane
expression caused by overexpression of AKAP79 (Figure 7E)
or activation of PKA by forskolin (Figure 7F). By contrast, muta-
tion of the S117 residue, which has been implicated in sensitiza-
tion of TRPV1 by PKA (Bhave et al., 2002), does not inhibit
AKAP79-dependent membrane trafficking (Figure 7G). These
experiments implicate phosphorylation of the S502 site as the
main mechanism by which AKAP79 mediates translocation of
TRPV1 to the surface membrane.
DISCUSSION
The experiments reported here show that inflammatory media-
tors acting via PKA or PKC depend completely on AKAP79/
150 to mediate their effects on TRPV1 (see summary diagram
in Figure 8). Two main mechanisms of sensitization have been
identified in previous studies: an enhancement of gating of
TRPV1 ion channels already in the membrane and an increase
in trafficking of TRPV1 to the membrane.
In the first and best-studied mechanism, mediators such as
PGE2 or bradykinin activate either PKA or PKC3, which phos-
phorylate TRPV1 and increase the probability of gating of the
channel by a wide range of activators. In the present study, we
find that sensitization of channel gating depends on the ability
of the relevant kinase to bind to AKAP79/150 and in turn on the
ability of AKAP79/150 to bind to TRPV1. The observation that
desensitization is reduced by deletion of PP2 binding site (bar 7; not significant
compared to bar 1, n = 5).
(E) Similar experiments in DRG neurons. Desensitization is reduced by inclu-
sion of peptide in patch pipette.
(F) Collected results of experiments on DRG neurons. Neurons selected with
initial currents between 1.0 and 2.0 nA. Significance level **, p < 0.01 compared
to first bar, n = 19.Neuron 59, 450–461, August 14, 2008 ª2008 Elsevier Inc. 457
Neuron
AKAP79 Controls Sensitivity of TRPV1Figure 7. AKAP79/150 Promotes Trafficking of TRPV1 to the Cell
Surface Membrane
(A) Surface membrane expression of TRPV1 in HEK293 cells, measured by bi-
otinylation of surface membrane TRPV1 in intact cells (Zhang et al., 2005), is
promoted by transfection with AKAP79. The effect of AKAP79 transfection is
inhibited by deletion of the PKA or PKC binding sites on AKAP79, but is not af-
fected by deletion of the PP2B (calcineurin) binding site. Lower image shows
parallel experiment in which total TRPV1 was probed in total cell lysate to dem-
onstrate constant loading of all lanes.
(B) Mean band density obtained in three independent experiments. ***, p <
0.001 compared to bar 1; ###, p < 0.001 compared to bar 2.
(C) Functional surface membrane expression of TRPV1 in HEK293 cells, mea-
sured in whole-cell voltage-clamp experiments in HEK293 cells from maximal
current elicited by a saturating dose of capsaicin (10 mM applied for 1 s). Note
that in these experiments, the very large currents can cause loss of voltage
clamp, and experiments were therefore carried out in [Na]o = 30 mM (see Ex-
perimental Procedures). Maximum current amplitude is increased by transfec-
tion of AKAP79 and is inhibited by downregulation of AKAP79 using siRNA.
(D) Mean results from experiments similar to (C). Maximum current density is
reduced by downregulation of endogenous AKAP79 using siRNA (bar 2; *,
p < 0.05 compared to bar 1; n = 20). AKAP79 transfection enhances maximum
current density (bar 3; **, p < 0.01 compared to bar 1; n = 42) but the effect is
negated by PKA or PKC site deletions, but not by PP2B site deletion. Bar 4, #,
p < 0.05 compared to bar 3, n = 28; bar 5, #, p < 0.05 compared to bar 3; bar 4,
not significantly different from bar 3, n = 24.
(E) Enhancement of TRPV1 trafficking to the membrane by AKAP79 depends
on the TRPV1 S502 site. Blots in (E)–(G) show surface membrane, obtained by
biotinylation of intact HEK293 cells, and total TRPV1 as in (A). The enhanced458 Neuron 59, 450–461, August 14, 2008 ª2008 Elsevier Inc.sensitization is completely abolished by disrupting either of
these binding mechanisms, or by removal of AKAP79/150 using
siRNA, implies that these two kinases must be preassembled in
a signaling complex with TRPV1 in order to have any effect and
thus that free PKA or PKC3 are unable to phosphorylate TRPV1
to any significant extent. The fact that inhibiting binding or re-
moving AKAP79/150 inhibits sensitization adds further evidence
to show that other possible mechanisms of sensitization, such as
depletion of membrane PIP2 following activation of PLC (Chuang
et al., 2001; Prescott and Julius, 2003), do not make any signifi-
cant contribution to sensitization of TRPV1 under physiological
conditions.
AKAP79/150 is also involved in trafficking of TRPV1 to the sur-
face membrane. Previous studies have shown that trafficking
can be promoted by phosphorylation of TRPV1 either by Src
(Zhang et al., 2005) or by PKC (Morenilla-Palao et al., 2004).
The first mechanism is insensitive to disruption of binding be-
tween AKAP79/150 and TRPV1, showing that Src does not de-
pend on AKAP79/150 to assemble it into a signaling complex
with TRPV1. The ability of PKC and PKA to enhance trafficking
does, however, depend absolutely on the presence of functional
AKAP79/150. We have shown that the main target of both ki-
nases in promoting trafficking is S502, a residue which is also in-
volved in the potentiation of channel gating (Numazaki et al.,
2002; Bhave et al., 2003).
We have concentrated mainly on the functional consequences
of binding of AKAP79/150 to TRPV1, but we have also obtained
biochemical evidence for interactions of AKAP79 with other
members of the thermo-TRP family, in particular TRPV4,
TRPM8, and TRPA1 (Figure 2). The functional consequences of
AKAP79 binding for the activation of these channels remain to
be explored.
We have identified a 14 aa domain in the C-terminal domain of
TRPV1 which mediates binding of AKAP79. Previous studies
have found that AKAP79 binds diffusely to other proteins (Col-
ledge et al., 2000), so the identification of a small binding domain
is something of a surprise. We did not find any obviously homol-
ogous binding domains on other thermo-TRPs, apart from an
area of weak homology between residues 705 and 724 of the
C-terminal domain of TRPA1, which suggests that AKAP79/
150 binds to other thermo-TRP proteins at nonhomologous
TRPV1 surface expression caused by cotransfection with AKAP79 is abolished
by the S502A mutation. Mean band densities from left, relative to major band at
top left: 1.0, 1.44, 1.0, 1.03, n = 3.
(F) Enhancement of TRPV1 trafficking to the membrane by PKA depends on
the S502 site. Forskolin (100 mM, 30 min) applied as shown to enhance PKA
activity. Mean band densities from left, relative to major band at top left: 1.0,
2.11, 1.0, 0.86, n = 3.
(G) Mutation of the S117 site, which has also been shown to be a target for PKA
(Bhave et al., 2002), has no effect on enhancement of translocation of TRPV1
to the membrane caused by overexpression of AKAP79. Final lane shows that
translocation caused by overexpression of AKA79 is partially PKA-dependent
as it is inhibited by the PKA inhibitor H89 (1 mM for 30 min). Mean band densi-
ties from left, relative to major band at top left: 1.0, 1.66, 1.85, 1.01, n = 2.
(H) Surface membrane expression of TRPV1 in HEK293 cells, measured by im-
munoprecipitation of HA-tagged surface membrane TRPV1 in intact cells (see
Experimental Procedures), is promoted by overexpression of AKAP79. Mean
band densities from left, relative to major band at top left: 1.0, 1.4, n = 1.
Neuron
AKAP79 Controls Sensitivity of TRPV1domains. A second possibility is that different intermediary pro-
teins are involved in the binding to other thermo-TRPs, as was
found for the binding of AKAP79/150 to the NMDA and AMPA re-
ceptors (Colledge et al., 2000).
The dependence of sensitization of TRPV1 on AKAP79/150
raises the possibility that disrupting binding may reverse heat hy-
peralgesia in vivo. The binding site of AKAP79/150 to TRPV1 may
therefore prove to be an attractive target for the development of
novel analgesics.
EXPERIMENTAL PROCEDURES
Methods were as described previously (Zhang et al., 2005) with the following
exceptions. Binding site deletions in AKAP79 for PKC, PKA, and PP2B were
performed using overlapping PCR to remove regions identified by Hoshi
et al. (2005). AKAP79 and binding-site deletion mutants were GFP coupled
so that successfully transfected cells could be identified in whole-cell patch-
clamp experiments. AKAP79 and AKAP150 were downregulated by using
siRNA constructs (Hoshi et al., 2005) but cloned into the GFP-expressing vec-
tor GFP-pGSH1 (Gelantis Inc) so that transfected cells could be identified from
their GFP fluorescence for patch-clamp studies. DRG neurons were trans-
fected using the Amaxa Nucleofector according to the manufacturer’s instruc-
tions. A peptide blocking the binding site between AKAP79 and TRPV1, and
scrambled control peptide (see Figure 2), were obtained from Sigma purified
to 75% purity.
Whole-cell patch-clamp recordings were carried out at a holding potential of
60 mV and at room temperature, as described previously (Zhang et al., 2005),
except for experiments in which activation of TRPV1 was explored as a func-
tion of membrane voltage (Figure 3), when the holding potential was 0 mV. Ex-
ternal solution for DRG neuron experiments contained 140 mM NaCl, 4 mM
KCl, 10 mM HEPES, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM glucose (pH
7.4), while for experiments with HEK293 cells (with the exception of those
shown in Figure 6), CaCl2 was replaced with 5 mM EGTA to inhibit desensiti-
zation. For recording maximal current density (Figure 7C), calcium-free
solution was used and [Na]o was reduced to 30 mM (substituted with choline
chloride) in order to reduce the maximum membrane current amplitude, as
described previously (Zhang et al., 2005). For experiments using inhibitory
Figure 8. AKAP79/150 Forms a Signaling Complex with TRPV1
The scaffolding protein AKAP79/150 binds to a 14 aa region in the C-terminal
domain of the heat-activated ion channel TRPV1 (orange cylinder). The forma-
tion of this scaffolding complex aligns PKC3, the phosphatase calcineurin
(PP2B) and PKA so as to control phosphorylation of key sites on TRPV1.
The principal site involved in control of trafficking of TRPV1 to the membrane
is S502. The tyrosine kinase Src can also promote trafficking to the membrane
by phosphorylating Y200 (Zhang et al., 2005) but does so independently of
AKAP79/150. TRPV1 has six ankyrin repeats in its N-terminal domain (Lishko
et al., 2007).peptide, DRG neurons were dialyzed with peptide-containing intracellular so-
lution for 10 min before starting recording.
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